Epstein-Barr virus (EBV) reactivation and cellmediated immune (CMI) responses were followed in 16 Antarctic expeditioners during winter-over isolation at 2 Australian National Antarctic Research Expedition stations. Delayedtype hypersensitivity (DTH) skin testing was used as an indicator of the CMI
Cell-mediated immunity against epstein-barr virus infected B lymphocytes
✍ Scribed by Klein, Eva ;Masucci, MariaGrazia
- Publisher
- Springer
- Year
- 1982
- Tongue
- English
- Weight
- 849 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0344-4325
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Twenty‐three patients with recent infectious mononucleosis were studied for cell‐mediated immunity to Epstein‐Barr virus (EBV)‐associated antigens. By means of a virion‐containing antigen preparation, (P3J), leukocyte migration inhibition was demonstrated in 6 of 13 patients with acute
## Abstract Regression of EB‐virus‐induced transformation occurs exclusively in cultures of leukocytes from seropositive donors. Studies have shown that the strength of regression could be assayed in terms of the proportion of T cells which must be added to the autologous EB virus‐infected T‐cell‐d
## Abstract Experiments have been conducted to determine the role played by immune T cells in the regression of EB‐virus‐induced transformation which is exclusively seen in leukocyte cultures from seropositive donors. Kinetic studies suggest that, In virus‐infected cultures from such donors, a popu
Although Epstein-Barr virus (EBV) positivity has been described in peripheral T-cell lymphomas (PTCLs) in Chinese patients, the cellular lineage of EBV-harbouring cells is unknown. Forty-four cases of PTCL were therefore studied by in situ hybridization (ISH) for EBV-encoded small non-polyadenylated